A
$ Value
$0
Shares
931
Price
$0
Filed
Mar 4
Insider
Name
Roque Vitor
Title
Interim CFO
CIK
0002098881
Roles
Officer
Transaction Details
Transaction Date
2026-03-02
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,510
Footnotes
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.
Filing Info
Other Insiders at BDX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RING TIMOTHY M | — | — | 2026-01-27 |
| ECKERT R ANDREW | — | — | 2026-01-27 |
| SCOTT BERTRAM L | — | $174K | 2026-02-18 |
| HAYES GREGORY | — | — | 2026-01-27 |
| Jones Christopher Ian Montague | — | — | 2026-02-04 |
| Henderson Jeffrey William | — | — | 2026-01-27 |
| Brown William M | — | — | 2026-01-27 |
|
Minnix Lanesha
EVP and General Counsel
|
— | — | 2026-03-16 |
| Huffines Robert Luther | — | — | 2026-02-04 |
|
Neal Shana Carol
EVP and Chief People Officer
|
— | — | 2026-04-06 |
| Wright Jacqueline | — | — | 2026-01-27 |
| Byington Carrie L | — | — | 2026-02-04 |
| Waldstreicher Joanne | — | — | 2026-01-27 |
|
Spikner Pamela L.
SVP Controller & CAO
|
— | — | 2026-03-02 |
|
Feld Michael
EVP, CRO & Pres. Life Sciences
|
— | $15K | 2026-01-26 |
|
Feld Michael
EVP, Chief Revenue Officer
|
— | $25K | 2026-03-26 |